|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goubran HA, Kotb RR, Stakiw J, Emara ME
and Burnouf T: Regulation of tumor growth and metastasis: The role
of tumor microenvironment. Cancer Growth Metastasis. 7:9–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Araki S, Omori Y, Lyn D, Singh RK,
Meinbach DM, Sandman Y, Lokeshwar VB and Lokeshwar BL:
Interleukin-8 is a molecular determinant of androgen independence
and progression in prostate cancer. Cancer Res. 67:6854–6862. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harada A, Sekido N, Akahoshi T, Wada T,
Mukaida N and Matsushima K: Essential involvement of interleukin-8
(IL-8) in acute inflammation. J Leukoc Biol. 56:559–564.
1994.PubMed/NCBI
|
|
6
|
Raman D, Baugher PJ, Thu YM and Richmond
A: Role of chemokines in tumor growth. Cancer Lett. 256:137–165.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gabellini C, Trisciuoglio D, Desideri M,
Candiloro A, Ragazzoni Y, Orlandi A, Zupi G and Del Bufalo D:
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human
malignant melanoma progression. Eur J Cancer. 45:2618–2627. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamohara H, Takahashi M, Ishiko T, Ogawa M
and Baba H: Induction of interleukin-8 (CXCL-8) by tumor necrosis
factor-alpha and leukemia inhibitory factor in pancreatic carcinoma
cells: Impact of CXCL-8 as an autocrine growth factor. Int J Oncol.
31:627–632. 2007.PubMed/NCBI
|
|
10
|
Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka
H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, et al: IL-8
promotes cell proliferation and migration through
metalloproteinase-cleavage proHB-EGF in human colon carcinoma
cells. Cytokine. 29:275–282. 2005.PubMed/NCBI
|
|
11
|
Merritt WM, Lin YG, Spannuth WA, Fletcher
MS, Kamat AA, Han LY, Landen CN, Jennings N, De Geest K, Langley
RR, et al: Effect of interleukin-8 gene silencing with
liposome-encapsulated small interfering RNA on ovarian cancer cell
growth. J Natl Cancer Inst. 100:359–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ning Y, Manegold PC, Hong YK, Zhang W,
Pohl A, Lurje G, Winder T, Yang D, Labonte MJ, Wilson PM, et al:
Interleukin-8 is associated with proliferation, migration,
angiogenesis and chemosensitivity in vitro and in vivo in colon
cancer cell line models. Int J Cancer. 128:2038–2049. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsuo Y, Ochi N, Sawai H, et al:
CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote
invasiveness and angiogenesis in pancreatic cancer. Int J Cancer.
124:853–861. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kitadai Y, Takahashi Y, Haruma K, Naka K,
Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, et
al: Transfection of interleukin-8 increases angiogenesis and
tumorigenesis of human gastric carcinoma cells in nude mice. Br J
Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT,
Kuo ML, Lee YC and Yang PC: Up-regulation of tumor interleukin-8
expression by infiltrating macrophages: Its correlation with tumor
angiogenesis and patient survival in non-small cell lung cancer.
Clin Cancer Res. 9:729–737. 2003.PubMed/NCBI
|
|
16
|
Ju D, Sun D, Xiu L, Meng X, Zhang C and
Wei P: Interleukin-8 is associated with adhesion, migration and
invasion in human gastric cancer SCG-7901 cells. Med Oncol.
29:91–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iwai M, Matsuda M and Iwai Y: Cloning of a
cancer cell-producing hepatocyte growth factor, vascular
endothelial growth factor and interleukin-8 from gastric cancer
cells. Vitro Cell Dev Biol Anim. 39:288–290. 2003. View Article : Google Scholar
|
|
18
|
Jin X, Zhu Z and Shi Y: Metastasis
mechanism and gene/protein expression in gastric cancer with
distant organs metastasis. Bull Cancer. 2014.((Epub ahead of
print)). PubMed/NCBI
|
|
19
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng JY and Liang H: Clinical significance
of lymph node metastasis in gastric cancer. World J Gastroenterol.
20:3967–3975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goubran HA, Kotb RR, Stakiw JI, Emara ME
and Burnouf T: Regulation of tumor growth and metastasis: The role
of tumor microenvironment. Cancer Growth Metastasis. 7:9–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin TA, Mason MD and Jiang WG: Tight
junctions in cancer metastasis. Front Biosci (Landmark Ed).
16:898–936. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campbell LM, Maxwell PJ and Waugh DJ:
Rationale and means to target pro-inflammatory interleukin-8
(CXCL8) signaling in cancer. Pharmaceuticals (Basel). 6:929–959.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gabellini C, Trisciuoglio D, Desideri M,
et al: Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on
human malignant melanoma progression. Eur J Cancer. 45:2618–2627.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Christofakis EP, Miyazaki H, Rubink DS and
Yeudall WA: Roles of CXCL8 in squamous cell carcinoma proliferation
and migration. Oral Oncol. 44:920–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu S, Shang H, Cui L, Zhang Z, Zhang Y, Li
Y, Wu J, Li RK and Xie J: Targeted blockade of interleukin-8
abrogates its promotion of cervical cancer growth and metastasis.
Mol Cell Biochem. 375:69–79. 2013.PubMed/NCBI
|
|
27
|
Wang Y, Xu RC, Zhang XL, Niu XL, Qu Y, Li
LZ and Meng XY: Interleukin-8 secretion by ovarian cancer cells
increases anchorage-independent growth, proliferation, angiogenic
potential, adhesion and invasion. Cytokine. 59:145–155. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luppi F, Longo AM, de Boer WI, Rabe KF and
Hiemstra PS: Interleukin-8 stimulates cell proliferation in
non-small cell lung cancer through epidermal growth factor receptor
transactivation. Lung Cancer. 56:25–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baggiolini M and Clark-Lewis I:
Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett.
307:97–101. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu YM and Woll PJ: Mitogenic effects of
interleukin-8/CXCL8 on cancer cells. Future Oncol. 1:699–704. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takagi A, Kamiya S, Koga Y, Ohta U,
Kobayashi H, Shirai T, Harasawa S and Miwa T: Analysis of
interleukin-8 secretion induced by Helicobacter pylori from the
gastric epithelial cell line MKN45: A mechanism independent of the
intensity of cytotoxicity. J Gastroenterol Hepatol. 12:368–372.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kitadai Y, Haruma K, Mukaida N, Ohmoto Y,
Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ
and Tahara E: Regulation of disease-progression genes in human
gastric carcinoma cells by interleukin 8. Clin Cancer Res.
6:2735–2740. 2000.PubMed/NCBI
|
|
33
|
Kitadai Y, Haruma K, Sumii K, Yamamoto S,
Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ and
Tahara E: Expression of interleukin-8 correlates with vascularity
in human gastric carcinomas. Am J Pathol. 152:93–100.
1998.PubMed/NCBI
|
|
34
|
Kido S, Kitadai Y, Hattori N, Haruma K,
Kido T, Ohta M, Tanaka S, Yoshihara M, Sumii K, Ohmoto Y and
Chayama K: Interleukin 8 and vascular endothelial growth
factor-prognostic factors in human gastric carcinomas? Eur J
Cancer. 37:1482–1487. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R and
Tang XJ: Interleukin-8 associates with adhesion, migration,
invasion and chemosensitivity of human gastric cancer cells. World
J Gastroenterol. 18:979–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Picker LJ, Nakache M and Butcher EC:
Monoclonal antibodies to human lymphocyte homing receptors define a
novel class of adhesion molecules on diverse cell types. J Cell
Biol. 109:927–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aruffo AI, Stamenkovic I, Melnick M,
Underhill CB and Seed B: CD44 is the principal cell surface
receptor for hyaluronate. Cell. 61:1303–1313. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Haynes BF, Telen MJ, Hale LP and Denning
SM: CD44 - a molecule involved in leukocyte adherence and T-cell
activation. Immunol Today. 10:423–428. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsieh HF, Yu JC, Ho LI, Chiu SC and Harn
HJ: Molecular studies into the role of CD44 variants in metastasis
in gastric cancer. Mol Pathol. 52:25–28. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Abbaszadegan MR, Moaven O, Sima HR,
Ghafarzadegan K, A'rabi A, Forghani MN, Raziee HR, Mashhadinejad A,
Jafarzadeh M, Esmaili-Shandiz E and Dadkhah E: p16 promoter
hypermethylation: A useful serum marker for early detection of
gastric cancer. World J Gastroenterol. 14:2055–2060. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zavrides HN, Zizi-Sermpetzoglou A,
Panousopoulos D, Athanasas G, Elemenoglou I and Peros G: Prognostic
evaluation of CD44 expression in correlation with bcl-2 and p53 in
colorectal cancer. Folia Histochem Cytobiol. 43:31–36.
2005.PubMed/NCBI
|
|
42
|
Wang DR, Chen GY, Liu XL, Miao Y, Xia JG,
Zhu LH and Tang D: CD44v6 in peripheral blood and bone marrow of
patients with gastric cancer as micro-metastasis. World J
Gastroenterol. 12:36–42. 2006.PubMed/NCBI
|
|
43
|
Jothy S: CD44 and its partners in
metastasis. Clin Exp Metastasis. 20:195–201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghaffarzadehgan K, Jafarzadeh M, Raziee
HR, Sima HR, Esmaili-Shandiz E, Hosseinnezhad H, Taghizadeh-Kermani
A, Moaven O and Bahrani M: Expression of cell adhesion molecule
CD44 in gastric adenocarcinoma and its prognostic importance. World
J Gastroenterol. 14:6376–6381. 2008. View Article : Google Scholar : PubMed/NCBI
|
